Bicyclic heteroaryl compounds as GPR119 modulators
AssigneeBristol-Myers Squibb Company
InventorsXiang-Yang Ye, Dean A. Wacker, Jeffrey A. Robl, Ying Wang
Life of this patent
Estimating the term…
Loading patent…
AssigneeBristol-Myers Squibb Company
InventorsXiang-Yang Ye, Dean A. Wacker, Jeffrey A. Robl, Ying Wang
Estimating the term…
Novel compounds of structure Formula I: or an enantiomer, diastereomer, tautomer, prodrug or salt thereof, wherein A, D, Di, E, J, L, n, Q, R2 and R4 are defined herein, are provided which are GPR119 G protein-coupled receptor modulators. GPR119 G protein-coupled receptor modulators are useful in treating, preventing, or slowing the progression of diseases requiring GPR119 G protein-coupled receptor modulator therapy. Thus, the disclosure also concerns compositions comprising these novel compounds and methods of treating diseases or conditions related to the activity of the GPR119 G protein-coupled receptor by using any of these novel compounds or a composition comprising any of such novel compounds.
A compound of formula IIa:
A compound of formula Va
A compound, enantiomer, diastereomer, tautomer or salt thereof, selected from the group consisting of:
Dependencies are inferred from the claim text.